Stefanie L. Cavanaugh - 07 Jul 2021 Form 4 Insider Report for Apollo Endosurgery, Inc.

Reporting relationship: CFO, Treasurer, Secretary
Issuer ticker: N/A
Reported as of: 07 Jul 2021
Net transaction value: $0
SEC form: 4
Accepted by SEC: 07 Jul 2021, 16:27:52 UTC
Next SEC filing: 18 May 2023
Source filing: View source filing
Reporting owner signature: /s/ Brian Szymczak - Attorney-in-Fact

Key filing fact

Stefanie L. Cavanaugh filed Form 4 for Apollo Endosurgery, Inc. on 07 Jul 2021.

Key facts

This page summarizes Stefanie L. Cavanaugh's Form 4 filing for Apollo Endosurgery, Inc..
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 07 Jul 2021, 16:27.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

APEN transaction

Common Stock

Other

Transaction value: $0
Shares: +91
Change %: +0.09%
Price: $0.000000
Shares after: 95,998
Date: 07 Jul 2021
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents shares of the Issuer's common stock paid as interest on $25,750 aggregate principal amount of the Reporting Person's 6.0% Convertible Debentures, or the Notes, previously reported, for the interest payment period from and including January 1, 2021, to, but excluding, July 1, 2021. Interest on the Notes is payable semi-annually in shares of the Issuer's common stock on January 1 and July 1 of each year at a rate of 6.00% per year and based on the volume-weighted average price of the Issuer's common stock for the 10 consecutive trading days immediately preceding the applicable interest payment date.